In mouse models, a role for Irs-2 in progression is demonstrated by the finding that knockout of Irs-2 expression inhibits PyMT-driven mouse mammary tumor metastasis and also suppresses tumor progression in Pten-/+ mice [21, 31]. Here, IRS2 is linked to neoplasm.